Cargando…
Integrated Clinical and Prognostic Analysis of the m(6)A RNA Methylation Regulator YTHDF3 in Pan-Cancer and its Correlation with Cancer Cell Proliferation
Background: N6-methyladenosine (m(6)A) is the most abundant and extensive chemical modification of mammalian RNA molecules. Although numerous studies have investigated m(6)A methylation-related genes, to the best of our knowledge, none have examined the expression patterns of YTH N6-methyladenosine...
Autores principales: | Cao, Leiqun, Zeng, Bingjie, Wang, Yulan, Wang, Xianzhao, Qin, Yueyang, Zhang, Congcong, Wu, Mengyi, Wang, Jiayi, Zhang, Xiao, Ma, Lifang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809312/ https://www.ncbi.nlm.nih.gov/pubmed/36606187 http://dx.doi.org/10.7150/jca.78403 |
Ejemplares similares
-
Differences in serum cytokine levels distinguish between clinically noninvasive lung adenocarcinoma and invasive lung adenocarcinoma: A cross‐sectional study
por: Zeng, Bingjie, et al.
Publicado: (2023) -
Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker
por: Liu, Weiwei, et al.
Publicado: (2022) -
YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021) -
YTHDF1 promotes the proliferation, migration, and invasion of prostate cancer cells by regulating TRIM44
por: Li, Weijian, et al.
Publicado: (2021) -
YTHDF3as a prognostic predictive biomarker of thyroid cancer and its correlation with immune infiltration
por: Zhang, Yihan, et al.
Publicado: (2023)